BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32239379)

  • 1. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
    Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
    Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
    Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
    Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
    Jia P; Wei E; Liu H; Wu T; Wang H
    IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 8. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
    Wu Q; Ma J; Meng W; Hui P
    Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
    Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
    Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
    Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
    Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
    Yu L; Luan W; Feng Z; Jia J; Wu Z; Wang M; Li F; Li Z
    Dig Liver Dis; 2021 Feb; 53(2):238-244. PubMed ID: 32952069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis.
    Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
    Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JHDM1D-AS1 aggravates the development of gastric cancer through miR-450a-2-3p-PRAF2 axis.
    Wu M; Liu Y; Pu YS; Ma Y; Wang JH; Liu EQ
    Life Sci; 2021 Jan; 265():118805. PubMed ID: 33245963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
    Tan J; Fan J; He J; Zhao L; Tang H
    J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.
    Zhu X; Ma X; Zhao S; Cao Z
    Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.
    Zhao H; Xu Q
    J Cell Mol Med; 2020 Nov; 24(21):12572-12584. PubMed ID: 32951317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.